"We will invest $100 million to build the first filler plant in California," announced Jaeyoung Kim, CEO of Jetema, a biopharmaceutical research, development, and...
Samsung Biologics’ upcoming $1.5-billion production plant will be ready for operation by April 2025, five months earlier than previously expected, according to the pharmaceutical...
